secwatch.observer — SEC 8-K summary
======================================

Issuer:     CNS Pharmaceuticals, Inc. (CNSP)
CIK:        0001729427
Form:       8-K
Filed at:   2025-02-21T23:59:59+00:00
Accession:  0001683168-25-001174
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 3.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CNS Pharmaceuticals announces 1-for-50 reverse stock split effective Feb 21, 2025
--------------------------------------------------------------------------------

- Reverse stock split at 1-for-50 ratio effective Feb 21, 2025; shares outstanding reduced from ~136.93M to ~2.74M.
- Split intended to increase per-share price to meet Nasdaq minimum bid price listing requirement.
- No fractional shares; stockholders receive cash in lieu of fractional shares based on closing price on effective date.
- Trading symbol remains "CNSP"; new CUSIP 18978H409; par value unchanged at $0.001.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1729427/000168316825001174/0001683168-25-001174-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1729427/000168316825001174/cns_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-25-001174

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer